SEC Form 4 · accession 0001193125-26-259976
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George W LeMaitre
Officer — Chairman and CEO · Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 5, 2026 · 5:29 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2026 | G | 11,974 | $0.00 | D | 1,418,045 | D | |
| Common StockF1 | Jun 4, 2026 | A | 11,974 | $0.00 | A | 45,374 | I | LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Equivalent RightsF2 | — | Jun 4, 2026 | A | 4 | A | — | — | Common Stock | 4 | 49 | D |
| Dividend Equivalent RightsF3 | — | Jun 4, 2026 | A | 4 | A | — | — | Common Stock | 4 | 49 | D |
| Dividend Equivalent RightsF4 | — | Jun 4, 2026 | A | 7 | A | — | — | Common Stock | 7 | 57 | D |
| Dividend Equivalent RightsF5 | — | Jun 4, 2026 | A | 8 | A | — | — | Common Stock | 8 | 61 | D |
| Dividend Equivalent RightsF6 | — | Jun 4, 2026 | A | 10 | A | — | — | Common Stock | 10 | 53 | D |
| Dividend Equivalent RightsF7 | — | Jun 4, 2026 | A | 11 | A | — | — | Common Stock | 11 | 54 | D |
| Dividend Equivalent RightsF8 | — | Jun 4, 2026 | A | 17 | A | — | — | Common Stock | 17 | 31 | D |
Explanation of responses
- F1These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
- F2These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F3These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F4These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F5These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F6These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F7These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F8These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.